Cargando…
Improving the safety of cell therapy products by suicide gene transfer
Adoptive T-cell therapy can involve donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation, the administration of tumor infiltrating lymphocyte expanded ex-vivo, or more recently the use of T cell receptor or chimeric antigen receptor redirected T cells. However, cellular...
Autores principales: | Jones, Benjamin S., Lamb, Lawrence S., Goldman, Frederick, Di Stasi, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245885/ https://www.ncbi.nlm.nih.gov/pubmed/25505885 http://dx.doi.org/10.3389/fphar.2014.00254 |
Ejemplares similares
-
Editorial: Improving the safety of cell therapy products by suicide gene transfer
por: Bole-Richard, Elodie, et al.
Publicado: (2015) -
Improving the safety of cell therapy with the TK-suicide gene
por: Greco, Raffaella, et al.
Publicado: (2015) -
Combinatorial suicide gene strategies for the safety of cell therapies
por: Falcon, Corey, et al.
Publicado: (2022) -
Suicide genes: monitoring cells in patients with a safety switch
por: Eissenberg, Linda G., et al.
Publicado: (2014) -
The inducible caspase-9 suicide gene system as a “safety switch” to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells
por: Gargett, Tessa, et al.
Publicado: (2014)